Anterior internal capsule volumes increase in patients with schizophrenia switched from typical antipsychotics to olanzapine

Journal of Psychopharmacology

Volumn 25, Issue 5, 2011, Pages 621-629

  Goghari, V M ^a   Lang, D J ^b   Khorram, B ^b   Gotz J ^b   Vandorpe, R A ^c   Smith, G N ^b   Kopala, L C ^b   Barr, A M ^b   Honer, W G ^b,d  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c DALHOUSIE UNIVERSITY   (Canada)

^d BC Mental Health and Addictions Research Institute   (Canada)

Author keywords

connectivity; corpus callosum; internal capsule; olanzapine; typical antipsychotics; white matter

Indexed keywords

NEUROLEPTIC AGENT; OLANZAPINE;

ADULT; ANTERIOR LIMB OF THE INTERNAL CAPSULE; ARTICLE; BRAIN SIZE; CAPSULA INTERNA; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS CALLOSUM; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; MALE; NERVE CELL NETWORK; NERVE TRACT; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTERIOR LIMB OF THE INTERNAL CAPSULE; PRIORITY JOURNAL; SCHIZOPHRENIA; WHITE MATTER;

ADULT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CASE-CONTROL STUDIES; CORPUS CALLOSUM; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERNAL CAPSULE; MAGNETIC RESONANCE IMAGING; MALE; SCHIZOPHRENIA; YOUNG ADULT;

EID: 79955457606     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881110363314     Document Type: Article

References (37)

1. Arnone D, McIntosh AM, Tan GM, Ebmeier KP. Meta-analysis of magnetic resonance imaging studies of the corpus callosum in schizophrenia. Schizophrenia Res. 2008 ; 101: 124-132
2. Axer H, Keyserlingk DG. Mapping of fiber orientation in human internal capsule by means of polarized light and confocal scanning laser microscopy. J Neurosci Meth. 2000 ; 94: 165-175
3. Bartzokis G, Lu PH, Nuechterlein KH, et al. Differential effects of typical and atypical antipsychotics on brain myelination in schizophrenia. Schizophrenia Res. 2007 ; 93: 13-22 (Pubitemid 46830753)
4. Bilder RM, Goldman RS, Volavka J, et al. Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder. Am J Psychiatry. 2002 ; 159: 1018-1028 (Pubitemid 34586949)
5. Cheung V, Cheung C, McAlonan GM, et al. A diffusion tensor imaging study of structural dysconnectivity in never-medicated, first-episode schizophrenia. Psychol Med. 2007 ; 38: 877-885
6. Clinton SM, Meador-Woodruff JH. Thalamic dysfunction in schizophrenia: neurochemical, neuropathological, and in vivo imaging abnormalities. Schizophrenia Res. 2004 ; 69: 237-253 (Pubitemid 38721422)
7. Dazzan P, Morgan KD, Orr K, et al. Different effects of typical and atypical antipsychotics on grey matter in first episode psychosis: the AESOP study. Neuropsychopharmacology. 2005 ; 30: 765-774 (Pubitemid 40397083)
8. De Lacoste MC, Kirkpatrick JB, Ross ED. Topography of the human corpus callosum. J Neuropath Exp Neurol. 1985 ; 44: 578-591 (Pubitemid 16196287)
9. Dorph-Petersen KA, Pierri JN, Perel JM, Sun Z, Sampson AR, Lewis DA. The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation: a comparison of haloperidol and olanzapine in macaque monkeys. Neuropsychopharmacology. 2005 ; 30: 1649-1661 (Pubitemid 43086022)
10. Goghari VM, Lang DJ, Flynn SW, Mackay AL, Honer WG. Smaller corpus callosum subregions containing motor fibers in schizophrenia. Schizophrenia Res. 2005 ; 73: 59-68 (Pubitemid 39574680)
11. Highley JR, Esiri MM, McDonald B, Cortina-Borja M, Herron BM, Crow TJ. The size and fibre composition of the corpus callosum with respect to gender and schizophrenia: a post-mortem study. Brain. 1999 ; 122: 99-110 (Pubitemid 29046276)
12. Holcomb HH, Cascella NG, Thaker GK, Medoff DR, Dannals RF, Tamminga CA. Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol. Am J Psychiatry. 1996 ; 153: 41-49 (Pubitemid 26026156)
13. Khorram B, Lang DJ, Kopala LC, et al. Reduced thalamic volume in patients with chronic schizophrenia after switching from typical antipsychotic medications to olanzapine. Am J Psychiatry. 2006 ; 163: 2005-2007 (Pubitemid 44807795)
14. Kopelman A, Andreasen NC, Nopoulos P. Morphology of the anterior cingulate gyrus in patients with schizophrenia: relationship to typical neuroleptic exposure. Am J Psychiatry. 2005 ; 162: 1872-1878 (Pubitemid 41428616)
15. Lahti AC, Weiler MA, Medoff DR, Tamminga CA, Holcomb HH. Functional effects of single dose first- and second-generation antipsychotic administration in subjects with schizophrenia. Psychiatry Res. 2005 ; 139: 19-30 (Pubitemid 40800434)
16. Lang DJ, Khorram B, Goghari VM, et al. Reduced anterior internal capsule and thalamic volumes in first-episode psychosis. Schizophrenia Res. 2006 ; 87: 89-99 (Pubitemid 44428117)
17. Lang DJ, Kopala LC, Vandorpe RA, et al. An MRI study of basal ganglia volumes in first-episode schizophrenia patients treated with risperidone. Am J Psychiatry. 2001 ; 158: 625-631 (Pubitemid 32289827)
18. Lang DJ, Kopala LC, Vandorpe RA, et al. Reduced basal ganglia volumes after switching to olanzapine in chronically treated patients with schizophrenia. Am J Psychiatry. 2004 ; 161: 1829-1836 (Pubitemid 39314677)
19. Lieberman JA, Tollefson GD, Charles C, et al. Antipsychotic drug effects on brain morphology in first-episode psychosis. Arch Gen Psychiatry. 2005 ; 62: 361-370 (Pubitemid 40471685)
20. Massana G, Salgado-Pineda P, Junque C, et al. Volume changes in gray matter in first-episode neuroleptic-naive schizophrenic patients treated with risperidone. J Clin Psychopharmacol. 2005 ; 25: 111-117 (Pubitemid 40395088)
21. Molina V, Reig S, Sanz J, et al. Changes in cortical volume with olanzapine in chronic schizophrenia. Pharmacopsychiatry. 2007 ; 40: 135-139 (Pubitemid 47434870)
22. Okugawa G, Nobuhara K, Takase K, Saito Y, Yoshimura M, Kinoshita T. Olanzapine increases grey and white matter volumes in the caudate nucleus of patients with schizophrenia. Neuropsychobiology. 2007 ; 55: 43-46 (Pubitemid 47000397)
23. Pandya DN, Rosene DL Epilepsy and the Corpus Callosum. Reeves AG, ed. New York: Plenum Press ; 1985: 21-39.
24. Pandya DN, Seltzer B Two Hemispheres-One Brain: Functions of the Corpus Callosum. Leporé P Ptito M Jasper HH, ed. New York: Alan R Liss ; 1986: 47-73.
25. Panenka WJ, Khorram B, Barr AM, et al. A longitudinal study on the effects of typical versus atypical antipsychotic drugs on hippocampal volume in schizophrenia. Schizophrenia Res. 2007 ; 94: 288-292 (Pubitemid 47031604)
26. Parikh V, Khan MM, Mahadik SP. Olanzapine counteracts reduction of brain-derived neurotrophic factor and TrkB receptors in rat hippocampus produced by haloperidol. Neurosci Lett. 2004 ; 356: 135-139 (Pubitemid 38121487)
27. Pillai A, Terry AV, Mahadik SP. Differential effects of long-term treatment with typical and atypical antipsychotics on NGF and BDNF levels in rat striatum and hippocampus. Schizophrenia Res. 2006 ; 82: 95-106 (Pubitemid 43202652)
28. Sakai K, Gao XM, Hashimoto T, Tamminga CA. Traditional and new antipsychotic drugs differentially alter neurotransmission markers in basal ganglia-thalamocortical neural pathways. Synapse. 2001 ; 39: 152-160 (Pubitemid 32104020)
29. Schlagenhauf F, Juckel G, Koslowski M, et al. Reward system activation in schizophrenic patients switched from typical neuroleptics to olanzapine. Psychopharmacology. 2008 ; 196: 673-684
30. Stephan KE, Magnotta VA, White T, et al. Effects of olanzapine on cerebellar functional connectivity in schizophrenia measured by fMRI during a simple motor task. Psychol Med. 2001 ; 31: 1065-1078 (Pubitemid 32725351)
31. Suzuki M, Zhou SY, Hagino H, et al. Volume reduction of the right anterior limb of the internal capsule in patients with schizotypal disorder. Psychiatry Res. 2004 ; 130: 213-225 (Pubitemid 38595424)
32. Vaidya VA, Marek GJ, Aghajanian GK, Duman RS. 5-HT2A receptor-mediated regulation of brain-derived neurotrophic factor mRNA in the hippocampus and the neocortex. J Neurosci. 1997 ; 17: 2785-2795 (Pubitemid 27155012)
33. Vita A, De Peri L. The effects of antipsychotic treatment on cerebral structure and function in schizophrenia. Int Rev Psychiatry. 2007 ; 19: 429-436
34. Walterfang M, Wood SJ, Velakoulis D, Pantelis C. Neuropathological, neurogenetic and neuroimaging evidence for white matter pathology in schizophrenia. Neurosci Biobehav Rev. 2006 ; 30: 918-948 (Pubitemid 44292852)
35. Witelson SF. Hand and sex differences in the isthmus and genu of the human corpus callosum: a postmortem morphological study. Brain. 1989 ; 112: 799-835 (Pubitemid 19151171)
36. Wobrock T, Kamer T, Roy A, et al. Reduction of the internal capsule in families affected with schizophrenia. Biol Psychiatry. 2008 ; 63: 65-71 (Pubitemid 350234883)
37. Zhou SY, Suzuki M, Hagino H, et al. Decreased volume and increased asymmetry of the anterior limb of the internal capsule in patients with schizophrenia. Biol Psychiatry. 2003 ; 54: 47-436